company background image
SVS

Solarvest BioEnergy TSXV:SVS Stock Report

Last Price

CA$0.11

Market Cap

CA$6.1m

7D

15.8%

1Y

0%

Updated

03 Dec, 2022

Data

Company Financials
SVS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

SVS Stock Overview

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally.

Solarvest BioEnergy Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Solarvest BioEnergy
Historical stock prices
Current Share PriceCA$0.11
52 Week HighCA$0.26
52 Week LowCA$0.04
Beta1.02
1 Month Change0%
3 Month Change22.22%
1 Year Change0%
3 Year Change-24.14%
5 Year Change-45.00%
Change since IPO-68.57%

Recent News & Updates

Recent updates

Shareholder Returns

SVSCA Personal ProductsCA Market
7D15.8%-0.3%0.4%
1Y0%-49.8%1.2%

Return vs Industry: SVS exceeded the Canadian Personal Products industry which returned -51.1% over the past year.

Return vs Market: SVS matched the Canadian Market which returned 0.6% over the past year.

Price Volatility

Is SVS's price volatile compared to industry and market?
SVS volatility
SVS Average Weekly Movement23.5%
Personal Products Industry Average Movement15.4%
Market Average Movement9.9%
10% most volatile stocks in CA Market18.0%
10% least volatile stocks in CA Market4.1%

Stable Share Price: SVS is more volatile than 90% of Canadian stocks over the past 3 months, typically moving +/- 24% a week.

Volatility Over Time: SVS's weekly volatility (24%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2005n/aClaes Ellegaardhttps://www.solarvest.ca

Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products in Canada and internationally. It provides human nutrition products, including omega-3; clean energy production system enables for continuous hydrogen production; and pharmaceutical ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to develop algae-based pharmaceutical grade cannabinoids.

Solarvest BioEnergy Inc. Fundamentals Summary

How do Solarvest BioEnergy's earnings and revenue compare to its market cap?
SVS fundamental statistics
Market CapCA$6.09m
Earnings (TTM)-CA$1.63m
Revenue (TTM)CA$1.03k

Over9,999x

P/S Ratio

-3.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SVS income statement (TTM)
RevenueCA$1.03k
Cost of RevenueCA$11.64k
Gross Profit-CA$10.61k
Other ExpensesCA$1.62m
Earnings-CA$1.63m

Last Reported Earnings

Jul 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.029
Gross Margin-1,034.01%
Net Profit Margin-158,662.87%
Debt/Equity Ratio-102.4%

How did SVS perform over the long term?

See historical performance and comparison